Distant Metastases from Laryngeal and Hypopharyngeal Cancer
Overview
Authors
Affiliations
A retrospective tumor registry analysis of patients with squamous cell carcinoma (SCC) of the larynx and hypopharynx who were treated with curative intent in the Department of Otolaryngology--Head and Neck Surgery at Washington University School of Medicine and Barnes Hospital between January 1971 and December 1991. In 2,550 patients, the mean age, sex and tumor differentiation did not affect the incidence of distant metastases. The overall incidence of distant metastases was 8.5% (217/2,550 patients) with the following distribution: glottis 4.4%, supraglottis 3.6%, subglottis 14%, aryepiglottic fold 16%, pyriform sinus 17% and posterior hypopharynx 17.6%. The overall 5-year disease-specific survival for distant metastases was 6.4%. Distant metastases were related to advanced local disease (T3 + T4), lymph node metastases at presentation (N+), tumor location (hypopharynx) and locoregional tumor recurrence (p < or = 0.028). A meta-analysis of variables which predispose to a higher incidence of distant metastases indicate that tumor location (hypopharynx > larynx), advanced primary disease (T3 + T4), regional disease (N+), locoregional recurrences, and advanced regional metastases (N2 + N3) are statistically significant.
Daloiso A, Franz L, Mondello T, Tisato M, Negrisolo M, Zanatta P Cancers (Basel). 2024; 16(22).
PMID: 39594842 PMC: 11592668. DOI: 10.3390/cancers16223887.
Mousavi S, Ilaghi M, Mirzazadeh Y, Mosavi Jarrahi A, Nejadghaderi S Front Oncol. 2024; 14:1398063.
PMID: 39286014 PMC: 11402725. DOI: 10.3389/fonc.2024.1398063.
Generation of a Realistic Synthetic Laryngeal Cancer Cohort for AI Applications.
Katalinic M, Schenk M, Franke S, Katalinic A, Neumuth T, Dietz A Cancers (Basel). 2024; 16(3).
PMID: 38339389 PMC: 10854797. DOI: 10.3390/cancers16030639.
18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma.
Suzuki S, Toyoma S, Abe T, Endo T, Kouga T, Kaswasaki Y J Otolaryngol Head Neck Surg. 2022; 51(1):13.
PMID: 35365214 PMC: 8973647. DOI: 10.1186/s40463-022-00568-8.
Metastatic disease in head & neck oncology.
Pisani P, Airoldi M, Allais A, Aluffi Valletti P, Battista M, Benazzo M Acta Otorhinolaryngol Ital. 2020; 40(SUPPL. 1):S1-S86.
PMID: 32469009 PMC: 7263073. DOI: 10.14639/0392-100X-suppl.1-40-2020.